Back to Freestone Grove Partners LP Freestone Grove Partners LP

PTGXPTGX
2 quarters

Position history for Freestone Grove Partners LPFreestone Grove Partners LP's holdings in PROTAGONIST THERAPEUTICS INC

Freestone Grove Partners LP previously held 0 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $0 as of 2025-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$256,458

Total Shares Change

-6,644

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$48.88
0
2024-Q4
New
6,644
-
$256,4580.0%$38.51
32

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used